Zenoject Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Sugammadex

Indications/Uses

Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients ≥2 yr.

Dosage/Direction for Use

IV Adult Routine reversal 4 mg/kg if recovery has reached at least 1-2 post-tetanic counts (PTC) following rocuronium- or vecuronium-induced blockade. 2 mg/kg if spontaneous recovery has occurred up to at least the reappearance of T₂ following rocuronium- or vecuronium-induced blockade. Immediate reversal of rocuronium-induced blockade 16 mg/kg. Post-op recurrence of neuromuscular blockade Repeat dose of 4 mg/kg after initial dose of 2 mg/kg or 4 mg/kg. Paed Routine reversal 4 mg/kg for reversal of rocuronium-induced blockade if recovery has reached at least 1-2 PTC. 2 mg/kg for reversal of rocuronium-induced blockade at reappearance of T₂.

Contraindications

Hypersensitivity.

MIMS Class

Antidotes & Detoxifying Agents

ATC Classification

V03AB35 - sugammadex ; Belongs to the class of antidotes. Used to reverse neuromuscular blockade caused by rocuronium or vecuronium.

Regulatory Classification

POM

Presentation/Packing

Form

Zenoject soln for inj 100 mg/mL

Packing/Price

1's

Zenoject

sugammadex

Manufacturer:

Mefar İlaç Sanayi AŞ